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Background: Alcoholic steatosis is the earliest and most common liver disease, and may precede the
onset of more severe forms of liver injury.
Methods: The effect of Korean Red Ginseng extract (RGE) was tested in two murine models of ethanol
(EtOH)-feeding and EtOH-treated hepatocytes.
Results: Blood biochemistry analysis demonstrated that RGE treatment improved liver function. Histo-
pathology and measurement of hepatic triglyceride content veriﬁed the ability of RGE to inhibit fat
accumulation. Consistent with this, RGE administration downregulated hepatic lipogenic gene induction
and restored hepatic lipolytic gene repression by EtOH. The role of oxidative stress in the pathogenesis of
alcoholic liver diseases is well established. Treatment with RGE attenuated EtOH-induced cytochrome
P450 2E1, 4-hydroxynonenal, and nitrotyrosine levels. Alcohol consumption also decreased phosphor-
ylation of adenosine monophosphate-activated protein kinase, which was restored by RGE. Moreover,
RGE markedly inhibited fat accumulation in EtOH-treated hepatocytes, which correlated with a decrease
in sterol regulatory element-binding protein-1 and a commensurate increase in sirtuin 1 and peroxisome
proliferator-activated receptor-a expression. Interestingly, the ginsenosides Rb2 and Rd, but not Rb1,
signiﬁcantly inhibited fat accumulation in hepatocytes.
Conclusion: These results demonstrate that RGE and its ginsenoside components inhibit alcoholic stea-
tosis and liver injury by adenosine monophosphate-activated protein kinase/sirtuin 1 activation both in
vivo and in vitro, suggesting that RGE may have a potential to treat alcoholic liver disease.
Copyright  2014, The Korean Society of Ginseng, Published by Elsevier. All rights reserved.1. Introduction
Alcoholic liver diseases (ALD) remain themost common cause of
liver-related morbidity and mortality worldwide [1]. Chronic
alcohol consumption leads to hepatic steatosis, which is the benign
form of ALD and most general response to heavy alcohol drinking.
ALD has a known cause, but the mechanisms by which alcohol
mediates ALD pathogenesis are incompletely deﬁned. A number of
factors play a key role in the pathogenesis and progression of ALD
including gender and ethnic differences, nutrition, dysregulation ofun University, Seosuk-dong, Dong-
il.com (S.H. Ki).
erms of the Creative Commons At
ribution, and reproduction in any
e Korean Society of Ginseng, Publenergy metabolism, immunologic mechanisms, and oxidative
stress [2].
Experimental and clinical studies increasingly show that
alcohol-induced oxidative stress is considered to be an early and
indispensable step in the development of ALD [3]. Several pathways
contribute to alcohol-induced oxidative stress. One of the central
pathways is through the induction of cytochrome P450 2E1
(CYP2E1) by alcohol, leading to the induction of lipid peroxidation
in hepatocytes [4]. Indeed, transgenic mice overexpressing CYP2E1
showed signiﬁcantly increased liver damage following alcoholgu, Gwangju 501-759, Korea.
tribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0)
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contrast, CYP2E1 knockout mice [6], and pharmacological in-
hibitors of CYP2E1 such as diallyl sulﬁde [7,8], phenethyl isothio-
cyanate [7,8], and chlormethiazole [9] decreased ethanol (EtOH)-
induced lipid peroxidation and pathologic alterations.
Chronic alcohol ingestion has been shown to increase levels of
sterol regulatory element-binding protein-1 (SREBP-1), a master
transcription factor that regulates lipogenic enzyme expression,
including fatty acid synthase (FAS), acetyl-CoA carboxylase (ACC),
and stearoyl-CoA desaturase-1 [10,11]. Alcohol intake also lowered
levels of peroxisome proliferator-activated receptor-a (PPARa), a
key transcriptional regulator of lipolytic enzymes, such as carniti-
nepalmitoyl-transferase-1 and uncoupling proteins [12]. In addi-
tion to regulating transcription factors associated with fat
metabolism, alcohol affects the activities of enzymes involved in
energy metabolism, including adenosine monophosphate-acti-
vated protein kinase (AMPK) and sirtuin 1 (Sirt1). AMPK, a
conserved cellular energy status sensor, is a serineethreonine ki-
nase that can phosphorylate and subsequently inactivate SREBP-1
in hepatocytes, thereby attenuating steatosis [13]. Expression of the
Sirt1, nicotinamide adenine dinucleotide-dependent class III his-
tone deacetylase, is decreased in mice fed with alcohol, resulting in
increased levels of SREBP-1 acetylation [14]. In addition, hepato-
cyte-speciﬁc knockout of Sirt1 impaired PPARa signaling and b-
oxidation, whereas overexpression of Sirt1 elevated the PPARa
target gene expression [15]. Hence, the AMPK/Sirt1 signaling axis is
a promising therapeutic target to attenuate lipogenesis and in-
crease lipolysis in ALD.
Korean ginseng (Panax ginseng Meyer) is one of the oldest and
most commonly used botanicals in the history of traditional Ori-
ental medicine. It has a variety of pharmacological activities,
including anti-inﬂammatory, -tumor, and -aging [16]. The ginseng
saponins, ginsenosides, play a key role in most physiological and
pharmacological actions of ginseng [17]. Korean Red Ginseng (KRG)
is heat- and steam-processed to enhance biological and pharma-
cological activities [18]. Red ginseng contains higher amounts of
ginsenosides, and some ginsenosides are only found in red ginseng
[19]. Studies have been shown that red ginseng has beneﬁcial ef-
fects on liver function. KRG protects aﬂatoxin B1- [20] and acet-
aminophen-induced hepatotoxicity [21] and increases liver
regeneration after partial hepatectomy [22] in animal models. We
recently reported that KRG effectively protects against liver ﬁbrosis
induced by chronic CCl4 treatment [23]. However, the effects of KRG
on alcohol-induced liver damage and the expression of lipogenic
genes have not yet been fully established.
In the present study, we examined the effect of KRG inmice after
chronic EtOH treatment and in EtOH-treated hepatocytes. Histo-
pathology and biochemical analysis veriﬁed the ability of KRG
extract (RGE) to protect against EtOH-induced fat accumulation and
oxidative stress, and to restore liver function. Moreover, RGE
recovered the activity of AMPK and Sirt1 in alcohol-fed mice. In
agreement with the in vivo data, RGE and its major ginsenosides
possess the ability to recover homeostatic lipid metabolism in he-
patocytes. These results demonstrate that KRG inhibits alcohol-
induced steatosis through the AMPK/Sirt1 signaling pathway in vivo
and in vitro, suggesting that KRG may have a potential to treat ALD.
2. Materials and methods
2.1. Materials
LiebereDeCarli liquid diet was purchased from Dyets, Inc.
(Bethlehem, PA, USA). Antibodies directed against CYP2E1, 4-
hydroxynonenal (4-HNE), PPARa, and SREBP-1 were supplied by
Abcam (Cambridge, UK). Antibodies that speciﬁcally recognizephosphorylated AMPK, AMPK, phosphorylated ACC, and Sirt1 were
obtained from Cell Signaling (Beverly, MA, USA). The nitrotyrosine
polyclonal antibody was purchased from Millipore Corporation
(Billerica, MA, USA). Horseradish peroxidase-conjugated goat anti-
rabbit immunoglobulin G and goat anti-mouse immunoglobulin G
were provided by Zymed Laboratories Inc. (San Francisco, CA, USA).
2.2. Preparation of RGE
RGE was kindly provided by KT&G Central Research Institute
(Daejeon, Korea). Brieﬂy, RGEwas obtained from 6-year-old roots of
P. ginsengMeyer. The ginseng was steamed at 90e100C for 3 h and
dried at 50e80C. The red ginseng was extracted six times with
water at 87C for 12 h. The water content of the pooled extract was
36% of the total weight. Ginsenosides (Rb1, Rb2, and Rd) were ob-
tained from Sigma-Aldrich Corporation (St Louis, MO, USA).
2.3. Animals and diets
Animal studies were conducted under the guidelines of the
Institutional Animal Use and Care Committee at Chosun University,
Gwangju, South Korea. C57BL6 mice were obtained from Oriental
Bio (Sungnam, Korea) and acclimatized for 1 week. Mice (n ¼ 8/
group) were given free access to either the control diet or the
LiebereDeCarli liquid diet containing EtOH with or without RGE.
The body weight and general condition of the animals were
monitored at least once a week. The diet was kept refrigerated in
the dark. EtOH was incorporated into the diet just before it was
supplied to the animals. We used two animal models to evaluate
the effect of RGE on alcohol-induced fatty liver and liver injury as
previously reported [24e26]. First, a model of chronic EtOH intake
was used. The mice were given free access to control diet or alcohol
LiebereDeCarli liquid diet for 4 weeks with or without RGE
(250 mg/kg or 500 mg/kg, per os, n ¼ 8) The mice were randomly
assigned to the groups speciﬁed. The second was a mouse model of
chronicebinge EtOH intake. Themicewere fedwith the control diet
for 5 days, and then divided into four groups. The EtOH groups were
fed with the LiebereDeCarli liquid diet containing 5% EtOH for 10
days with or without RGE (250 mg/kg or 500 mg/kg, per os, n ¼ 8).
The control groups were pair-fed the control diet for 10 days. At Day
11, mice in EtOH groups were gavaged a single dose of EtOH (5 g/kg
body weight, 20% EtOH), whereas mice in control groups were
gavaged isocaloric dextrin maltose. The mice were sacriﬁced 9
hours after gavage.
2.4. Cell culture
AML12 cell lines were purchased from ATCC (Manassas, VA, USA).
Cells were plated at a density of 3  105/well in 60 mm dishes and
grown to 70e80% conﬂuency. Cells were maintained in Dulbecco’s
Modiﬁed Eagle Medium: Nutrient Mixture F-12 containing 10% fetal
bovine serum(Hyclone, Logan,UT,USA), 50units/mLpenicillin, 50mg/
mL streptomycin, 0.005 mg/mL insulin, 0.005 mg/mL transferrin,
5 ng/mL selenium, and 40 ng/mL dexamethasone at 37C in a hu-
midiﬁed atmosphere with 5% CO2. RGE or ginsenosides were dis-
solved in phosphate-buffered saline (PBS) and added to the cells. The
cells were then incubated at 37C for the indicated time period, and
washed twice with ice-cold PBS prior to sample preparation.
2.5. Blood chemistry
Plasma alanine aminotransferase (ALT) and aspartate amino-
transferase (AST) were analyzed using Spectrum, an automatic
blood chemistry analyzer (Abbott Laboratories, Abbott Park, IL,
USA).
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Fig. 1. Korean Red Ginseng extract (RGE) treatment prevents chronic ethanol-induced liver injury. (A) Feeding protocol. Mice were fed with pair-fed control or alcohol-containing
diet (EtOH) for 4 weeks. During the feeding, the animals were orally administered with RGE ﬁve times/week. (B) Alanine aminotransferase (ALT) and aspartate aminotransferase
(AST) activities were monitored in the serum of the mice. Values represent mean  standard deviation from eight animals (signiﬁcantly different from vehicle-treated control,
**p < 0.01, or EtOH alone, #p < 0.05 or ##p < 0.01). (C) Histopathology in mice. Hematoxylin and eosin-stained sections represent liver samples of mice fed control diet (control),
alcohol-containing diet (EtOH), and alcohol-containing diet with RGE. EtOH ¼ ethanol.
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Samples from the liver were separated and ﬁxed in 10% neutral
buffered formalin. The samples were then embedded in parafﬁn,
sectioned (3e4 mm), and stained with hematoxylin and eosin (H&E)
for general histopathological analysis. In addition, the effect of RGE
treatment on the 4-HNE and nitrotyrosine immunoreactivity was
also observed by immunohistochemical methods.2.7. Oil Red O staining
For the analysis of fat accumulation in the liver, 10-mm sections
were cut from frozen samples and stained with Oil Red O for
10 min. The slides were rinsed in water and counterstained with
Mayer’s hematoxylin, followed by analysis using light microscopy.
Lipid droplet formation in hepatocytes was determined by Oil Red
O staining. Cells were grown on a six-well plate. After treatment,
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Fig. 2. Korean Red Ginseng extract (RGE) treatment inhibits chronic EtOH-induced fat
accumulation in liver. (A) Hepatic triglyceride content was measured in lipid extracts.
Data represent mean  standard deviation from eight animals (signiﬁcantly different
from vehicle-treated control, **p < 0.01, or EtOH alone, ##p < 0.01). (B) Morphology in
frozen liver sections as determined by Oil Red O staining. EtOH ¼ ethanol.
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60% isopropanol. Cells were then stained with Oil Red O solution.
2.8. Hepatic lipid contents
Hepatic lipid content was measured as described previously
[25]. Brieﬂy, lipids from the total liver homogenate were extracted
using chloroform/methanol (2:1), evaporated, and dissolved in 5%
triton X-100. Triglyceride content was determined using Sigma
Diagnostic Triglyceride Reagents (Sigma).
2.9. Immunoblot analysis
Samples were individually prepared from animals or AML12
cells treated as described above, and subjected to immunoblotting.
Immunoblot analyses were performed according to a previously
published procedure [24]. Proteins of interest in liver homogenates
were resolved using a 9% or 12% gel and developed using an ECL
chemiluminescence system (Amersham, Buckinghamshire, UK).
2.10. RNA isolation and real-time reverse transcription polymerase
chain reaction analysis
Total RNA was extracted using Trizol (Invitrogen, Carlsbad,
CA,USA) according to the manufacturer’s instructions. To obtain
cDNA, total RNA (1 mg) was reverse-transcribed using an oligo(dT)16
primer. The cDNA was ampliﬁed using a high capacity cDNA syn-
thesis kit (Bioneer, Daejon, Korea) with a thermal cycler (Bio-rad,
Hercules, CA, USA). Real-time polymerase chain reaction (PCR) was
performed with STEP ONE (Applied Biosystems, Foster City, CA,
USA) using a SYBR green premix according to the manufacturer’s
instructions (Applied Biosystems). Primers were synthesized by
Bioneer. The following primer sequences were used: mouse SREBP-
1 50- GAGGCCAAGCTTTGGACCTGG-30 (sense) and 50-
CCTGCCTTCAGGCTTCTCAGG-30 (antisense); mouse FAS 50- ATTG
CATCAAGCAAGTGCAG-30 (sense) and 50- GAGCCGTCAAACAGGAA
GAG-30 (antisense); mouse ACC 50- TGAAGGGCTACCTCTAATG-30
(sense) and 50- TCACAACCCAAGAACCAC-30 (antisense); mouse
PPARa 50- CTGCAGAGCAACCATCCAGAT-30 (sense) and 50-
GCCGAAGGTCCACCATTTT -30 (antisense); and mouse Sirt1 50-
ATCGGCTACCGAGACAAC-30 (sense) and 50- GTCACTA
GAGCTGGCGTGT-30 (antisense). The relative level of PCR products
was determined on the basis of the threshold cycle value. Glycer-
aldehyde-3-phosphate dehydrogenase was used as a reference
gene for normalization. Melting curve analysis was done after
ampliﬁcation to verify the accuracy of the amplicon.
2.11. Data analysis
One-way analysis of variance was used to assess signiﬁcant
differences among treatment groups. The NewmaneKeuls test was
used for comparisons of group means. Statistical analyses were
carried out using IBM-SPSS Statistics ver. 21.0 (IBM Corporation,
Armonk, NY, USA) for Windows software. Data represent the
mean  standard deviation. The criterion for statistical signiﬁcance
was set at p < 0.05 or p < 0.01.
3. Results
3.1. Treatment with RGE improves chronic alcohol-induced
histopathological changes
We ﬁrst evaluated the effects of RGE on EtOH-induced steatosis.
To induce alcoholic steatosis, we adopted the most commonly used
voluntary feeding model with the LiebereDeCali diet containingEtOH (Fig. 1A). After 4 weeks of alcohol feeding, serum ALT and AST
levels were signiﬁcantly increased. The EtOH-induced elevation in
ALT and AST was notably decreased by concomitant treatment with
250 mg/kg or 500 mg/kg RGE (5 times/week, per os; Fig. 1B). To
verify the effects of RGE on alcoholic steatosis, we performed his-
topathological analysis of changes in fat accumulation. Hepatic
steatosis was observed in all of the EtOH-fed groups. However,
alcohol-induced hepatic steatosis was markedly and dose-depen-
dently inhibited by treatment of 250 mg/kg and 500 mg/kg RGE
(Fig. 1C). Our data veriﬁed that RGE treatment improves alcohol-
induced fatty liver.3.2. Treatment with RGE decreases in hepatic triglyceride content
To ﬁrmly establish the effects of RGE on alcoholic steatosis,
hepatic triglyceride levels were measured. The increase in hepatic
triglyceride accumulation after EtOH feeding was signiﬁcantly
inhibited by RGE treatment (Fig. 2A). Lipid accumulation was also
assessed by Oil Red O staining. Control mice did not show steatosis,
whereas EtOH-fed mice exhibited a substantial increase in lipid
droplets, which was in line with the results of H&E microscopy
(Fig. 2B). RGE completely inhibited lipid inﬁltration in the liver,
conﬁrming the ability of RGE to prevent hepatic fat accumulation.
The expression of hepatic fat metabolism-related genes was also
assessed by quantitative real-time PCR. As shown in Fig. 3A, hepatic
expression of several lipogenic gene, including SREBP-1, FAS, and
ACC was upregulated by EtOH feeding. This enhancement was
completely reversed by RGE treatment. As previously reported,
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genes, such as Sirt1 and PPARa. However, RGE prevented EtOH-
mediated decreases in lipogenic gene expression (Fig. 3A).
Furthermore, RGE abolished the EtOH-induced enhancement
SREBP-1 and depletion of PPARa protein in the liver (Fig. 3B). These
results demonstrate that RGE inhibits EtOH-induced lipogenesis
and restores alcohol-mediated decreases in fatty acid oxidation.3.3. Treatment with RGE inhibits chronic alcohol-induced oxidative
stress
Sustained exposure to EtOH leads to prolonged oxidative stress,
which promotes lipid peroxidation and generation of reactive al-
dehydes, such as 4-HNE [27]. Previously, 4-HNE-positive cells were
markedly increased in mice fed alcohol. However, RGE treatment
led to a signiﬁcant, dose-dependent reduction in 4-HNE positive
cells (Fig. 4A). These data provide direct evidence that RGEB  A  
Fig. 3. Korean Red Ginseng extract (RGE) treatment improves fat metabolism gene proﬁle. (A
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to protect hepatocytes from necrotic changes caused by EtOH.
It is well known that prolonged reactive oxygen species (ROS)
exposure leads to increased nitrotyrosine levels [28]. Nitrotyrosine
immunoreactive cells were increased in the chronic EtOH-admin-
istration group as compared with the control. However, RGE
treatment dramatically reduced the number of nitrotyrosine posi-
tive cells (Fig. 4B). We next assessed whether RGE treatment
inhibited the induction of CYP2E1 caused by chronic alcohol intake.
As anticipated, RGE signiﬁcantly repressed the induction of CYP2E1
by EtOH (Fig. 4C). Our present data suggest that RGE protects
against chronic alcohol-induced oxidative stress and hepatic injury.3.4. RGE treatment prevents chronic alcohol-mediated AMPK
phosphorylation
Next, we examined whether the effect of RGE on hepatic stea-
tosis is associated with AMPK activation. Immunoblot analysis) Real-time reverse transcription polymerase chain reaction analysis. Mice were treated
nes were analyzed by real-time reverse transcription polymerase chain reaction assays,
tion. (B) Immunoblotting. Sterol regulatory element-binding protein (SREBP-1) and
red from mice treated as described in the legend to Fig. 1. Equal loading of protein was
from eight animals. Statistical signiﬁcance of the differences between each treatment
#p < 0.01, N.S.; not signiﬁcant) was determined.
Fig. 4. Korean Red Ginseng extract (RGE) treatment abrogates chronic alcohol-induced oxidative stress. (A) 4-hydroxynonenal (4-HNE). Representative immunohistochemical
staining of 4-HNE positive cells in liver section. (B) Nitrotyrosine. Representative immunohistochemical staining of nitrotyrosine positive cells in liver section. Statistical signiﬁcance
of the differences between each treatment group and the vehicle-treated control (**p < 0.01) or ethanol (EtOH) alone (##p < 0.01) was determined. (C) Cytochrome P450 2E1
(CYP2E1) was immunoblotted in the samples prepared from mice treated as described in the legend to Fig. 1. Equal loading of proteins was veriﬁed by probing the replicate blots for
b-actin.
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Fig. 5. Korean Red Ginseng extract (RGE) treatment increased adenosine mono-
phosphate-activated protein kinase-a (AMPKa) phosphorylation. Phosphorylated
AMPKa and acetyl-CoA carboxylase (ACC) was immunoblotted in the liver homoge-
nates prepared from mice. Equal loading of proteins was veriﬁed by probing the
replicate blots for AMPK.
J Ginseng Res 2015;39:105e115110showed that the level of phosphorylated AMPKa in liver homoge-
nates notably decreased after 4 weeks of alcohol administration as
previously reported (Fig. 5) [24]. Treatment of alcohol-fed mice
with RGE resulted in a complete recovery of AMPKa phosphoryla-
tion levels. We further measured the levels of phosphorylated ACC,
a direct downstream substrate of AMPK. Consistent with AMPKa
phosphorylation, alcohol consumption inhibited ACC phosphory-
lation in the liver, and phosphorylation levels were recovered after
RGE treatment. Our results demonstrate that chronic alcohol
feeding results in a decrease in AMPK activity, which is recovered
by RGE treatment.
3.5. Treatment with RGE prevents chronic-binge EtOH-induced liver
injury
Previously, we reported that feedingmice with a LiebereDeCarli
diet containing 5% EtOH for 10 days, followed by a single dose of
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eosin-stained sections represent liver samples of mice fed control diet (control), alcohol-containing diet (EtOH), and alcohol-containing diet with RGE. EtOH ¼ ethanol.
J.Y. Han et al / KRG and alcoholic steatosis 111EtOH gavage (5 g/kg body weight) (chronicebinge EtOH model)
induces signiﬁcant fatty liver and liver injury with oxidative stress
(Fig. 6A) [25]. To investigate the effect of RGE for the treatment of
ALD using the chronicebinge EtOH model, EtOH-fed mice weretreated with RGE. Treatment with RGE decreased EtOH-induced
serum ALT and AST levels (Fig. 6B). The protective effect of RGE on
alcoholic steatosis was further conﬁrmed by liver histology as
shown by H&E staining. It was noted that treatment of alcohol-fed
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Fig. 7. Korean Red Ginseng extract (RGE) treatment abrogates chronic-binge EtOH-induced oxidative stress. Representative immunohistochemical staining of immunoreactive cells
in liver section. (A) 4-hydroxynonenal (4-HNE). (B) Nitrotyrosine. Statistical signiﬁcance of the differences between each treatment group and the vehicle-treated control
(**p < 0.01) or EtOH alone (##p < 0.01) was determined. EtOH ¼ ethanol.
J Ginseng Res 2015;39:105e115112mice with RGE completely inhibited fat inﬁltration (Fig. 6C), con-
ﬁrming the ability of RGE to inhibit fat accumulation in liver.
Moreover, the chronicebinge EtOH model signiﬁcantly
increased 4-HNE positive cells, which is consistent with our pre-
vious report [25]. However, similar to the chronic EtOH model, the
amount of 4-HNE positive cells was dose-dependently and signif-
icantly reduced by treatment with RGE (Fig. 7A). RGE also markedly
attenuated nitrotyrosine positive cells, conﬁrming that RGE is
capable of inhibiting alcohol-induced oxidative stress in the
chronicebinge EtOH animal model (Fig. 7B).3.6. Treatment with RGE prevents EtOH-induced fat accumulation
in AML12 cells
We next examined the effect of RGE on fat accumulation in a
mouse hepatocyte cell line, AML12. EtOH treatment for 3 days
increased fat accumulation in hepatocytes as shown by Oil red O
staining. However, RGE (500 mg/mL or 1000 mg/mL) treatment
reduced fat accumulation in a dose-dependent manner (Fig. 8A). To
determine whether changes of fat accumulation in the hepatocyte
were consistent with lipogenesis- or lipolytic-associated gene
expression, the expression of SREBP-1, Sirt1, and PPARa was
observed by Western blot analysis following concomitant treat-
ment with 10e1000 mg/mL of RGE and EtOH for 3 days. In agree-
ment with the in vivo data, RGE inhibited the ability of EtOH to
induce SREBP-1 and repress Sirt1 and PPARa expression in AML12
cells (Fig. 8B).3.7. Treatment with the major ginsenosides from red ginseng
suppresses EtOH-induced fat accumulation in AML12 cells
The pharmacological properties of ginseng are primarily
attributed to a group of active ingredients, the ginsenosides, which
are a diverse group of steroidal saponins. Gum and Cho recently
reported that total ginsenoside amount of RGE was 19.66 mg/g
containing the major ginsenosides Rb1 (4.62 mg/g), Rb2 (1.83 mg/
g), Rc (2.41 mg/g), Rd (0.89 mg/g), Re (0.93 mg/g), Rf (1.21 mg/g),
Rg1 (0.71mg/g), Rg2 (3.21 mg/g), Rg3 (3.05mg/g), Rh1 (0.78 mg/g),
and other minor ginsenosides [21]. Therefore, we next identiﬁed
the major component of red ginseng required for the inhibition of
hepatic steatosis. We determined the effects of the major ginse-
nosides Rb1, Rb2, and Rd on the EtOH-induced fat accumulation in
AML12 cells. Interestingly, the ginsenosides Rb2 and Rd, but not
Rb1, inhibited EtOH-induced fat accumulation, as shown by Oil red
O staining (Fig. 9A). Consistent with this, Rb2 and Rd signiﬁcantly
reversed EtOH-mediated Sirt1 and PPARa suppression (Fig. 9B). The
results suggest that RGE and its major ginsenosides inhibit alcohol-
induced fatty liver and liver injury through the recovery of ho-
meostatic lipid metabolism in the liver.4. Discussion
ALD, which ranges from simple fatty liver to cirrhosis and he-
patocellular carcinoma, remains a major cause of liver-associated
mortality worldwide [29]. Early research on the pathogenesis of the
(a) Control (b) EtOH
(c) EtOH + RGE 500 (d) EtOH + RGE 1000
A 
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B
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Fig. 8. Korean Red Ginseng extract (RGE) treatment inhibits alcohol-induced fat
accumulation in AML12 cells. (A) Oil Red O staining. The cells were treated with the
indicated concentrations of RGE for 3 days with EtOH in AML12 cells. Cells were ﬁxed
formaldehyde, stained with Oil red O, and observed under a Leica microscope (Wetzlar,
Germany). (B) Sterol regulatory element-binding protein (SREBP-1), sirtuin (Sirt1), or
peroxisome proliferator-activated receptor-a (PPARa) expression was assessed in the
lysates by immunoblotting. The results were conﬁrmed by three independent exper-
iments. Equal loading of proteins was veriﬁed by probing the replicate blots for b-actin.
EtOH ¼ ethanol.
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  Sirt1
PPARα
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Fig. 9. Ginsenosides from red ginseng inhibit alcohol-induced fat accumulation in AML12
ginsenosides for 3 days with ethanol (EtOH) in AML12 cells. Cells were ﬁxed in formaldehy
(Sirt1) or peroxisome proliferator-activated receptor-a (PPARa) was assessed in the lysates
Equal loading of proteins was veriﬁed by probing the replicate blots for b-actin. EtOH ¼ et
J.Y. Han et al / KRG and alcoholic steatosis 113ALD primarily focused on alcohol metabolism-related oxidative
stress, malnutrition, and activation of Kupffer cells by endotoxins
[30,31]. Recently, the characterization of intra- and intercellular
signaling pathways, innate and adaptive immune responses,
epigenetic features, microRNAs, and stem cells has improved our
knowledge of the pathobiology of ALD [31]. Despite improved un-
derstanding of the pathophysiology of ALD, there is no Food and
Drug Administration-approved drug for the speciﬁc treatment of
ALD. Therefore, the development of effective therapeutic strategies
for ALD is pivotal.
KRG has been shown to exhibit several beneﬁcial effects in the
treatment of liver diseases through the regulation of immune
function and antioxidant activity [16]. However, the effects of KRG
on alcohol-induced hepatic steatosis and oxidative stress have not
been fully established. Here, we established the effects of RGE on
alcohol-induced liver injury in vivo and in vitro and identiﬁed the
major component of KRG with beneﬁcial effects in ALD. Ginseng
saponins, referred to as ginsenosides, play a major role in most
pharmacological actions of ginseng; however, until now, the role of
ginsenosides on EtOH-induced fat accumulation has remained
observed. Interestingly, the ginsenosides Rb2 and Rd, but not Rb1,
signiﬁcantly restored EtOH-induced Sirt1 and PPARa suppression
(Fig. 9B), consistent with RGE treatment to the mice. Moreover, the
ginsenosides Rb2 and Rd inhibited EtOH-induced fat accumulation
in AML12 cells (Fig. 9A). The increased lipolytic gene expression and
inhibition of fat accumulation resulting from treating by RGE and
its major ginsenosides indicates that RGE may be a promising
hepatoprotective candidate against liver injury.
During the last 5 decades, several animal models of ALD have
been studied, which has helped us understand the molecular basis
of ALD. The most widely used model for ALD is the LiebereDeCarli
EtOH-containing diet, which is a liquid diet-based voluntary
feeding model. Recently, we have developed and reported a moreEtOH
  -         Rb1     Rb2    Rd
(g) EtOH + Rd 1 μg/mL(h) EtOH + Rd 10 μg/mL
(c) EtOH + Rb1 1 μg/mL  (d) EtOH + Rb1 10 μg/mL
cells. (A) Oil Red O staining. Cells were treated with the indicated concentrations of
de, stained with Oil red O, and observed under microscope. (B) Expression of sirtuin 1
by immunoblotting. The results were conﬁrmed by three independent experiments.
hanol.
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model in mice), which is similar to drinking patterns in ALD pa-
tients who have a background of long-term drinking (chronic) and
a history of recent heavy alcohol use (binge) [25,26]. Such chronice
binge EtOH feeding induced severe hepatic steatosis, oxidative
stress, and inﬂammation in mice. Other laboratories have also
conﬁrmed the effect of the chronicebinge EtOH model in mice and
rats [32,33]. Here we used two animal models, the chronic EtOH
model and chronic-binge EtOH model to investigate the effect of
RGE for the treatment of ALD. Treatment with RGE improved
alcoholic fatty liver and liver injury in both models.
Alcohol is primarily metabolized in the liver by oxidative
enzymatic breakdown by alcohol dehydrogenase. In addition, the
microsomal electron transport system also regulates alcohol
metabolism via catalysis by CYP2E1. CYP2E1 expression is induced
during chronic alcohol consumption, and results in the formation of
ROS and free radicals [3,4]. CYP2E1 also promotes the formation of
highly reactive aldehydes, including acetaldehyde, 4-HNE, and
MDA, which can form protein adducts. In the current study, we
measured the CYP2E1 protein level through western blot (Fig. 4C)
and 4-HNE and nitrotyrosine protein adducts, two major products
of ROS and reactive nitrogen species, respectively, by immunohis-
tochemistry (Figs. 4A and B, 7A and B). Treatment of mice with RGE
was capable of inhibiting CYP2E1 induction caused by chronic
alcohol consumption. In addition, 4-HNE-positive cells and nitro-
tyrosine-immunoreactive cells were signiﬁcantly reduced after
treatment with RGE. Thus, the beneﬁcial effect of RGE against
alcohol-induced fat accumulation and liver injury may be medi-
ated, at least in part, through the inhibition of oxidative stress.
In recent years, several novel mechanisms regulating the path-
ogenesis of ALD have been described. Chronic alcohol ingestion in
animal models is associated with impairment of the hepatic AMPK/
Sirt1 axis, a central signaling pathway regulating energy meta-
bolism [14,34]. The activation of AMPK/Sirt1 signaling in liver has
been found to increase fatty acid oxidation and repress lipogenesis,
primarily by modulating activity of SREBP-1 or PPARg coactivator-
a/PPARa [35,36]. Here, we conﬁrmed that AMPK phosphorylation
was signiﬁcantly decreased after alcohol administration. Treatment
of alcohol-fed mice with RGE restored AMPKa and ACC phophor-
ylation levels (Fig. 5). Moreover, treatment of AML12 cells with RGE
and ginsenosides resulted in a complete recovery of the Sirt1 and
PPARa suppression induced by EtOH (Figs. 8 and 9). Consistent with
this, RGE and ginsenosides inhibited EtOH-induced SREBP-1
expression and fat accumulation as evidenced by Oil red O staining
in AML12 cells. These results indicate that the effect of RGE on
alcoholic fatty liver and liver injury may be due to improvement of
homeostatic lipid metabolism in the liver.
In summary, our present study demonstrated for the ﬁrst time
that RGE and major ginsenosides efﬁcaciously ameliorated alcohol-
induced fatty liver and liver injury through improving hepatic en-
ergy metabolism and prevention of oxidative stress. The effect of
RGE and ginsenosides may be due to the activation of AMPK/Sirt1
signaling pathway. Therefore, our study provides crucial informa-
tion about the possible use of KRG as a clinical candidate for the
prevention and treatment of ALD.
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